Complementary Medicine coMedicine

https://nccih.nih.gov/sites/nccam.nih.gov/files/styles/original_squ/public/diabetes%20diabetic_ThinkstockPhotos-518430316_squares.jpg
http://aaqg-arunarya.blogspot.in/2017/08/complementary-medicine-comedicine.html

Allopathic medicine, as practiced over 50 years, isexcellent and scientific for acute care, however very poor for chronic care. Aaqgs-I believe that lacuna is a consequence of the limitation of the standard evidence based dose-response method used by traditional medicine for 50% useful outcomes in chronic care, as opposed to 100% in acute care.

This general indictment does not support other medicine systems that also pass as complementary medicine, or even general applications of parts of medicine like osteopathy or chiropractic. It simply posits that my approach is better evidence based scientific. Given there is no clear definition of these terms, I begin by explaining what I mean.

A scientific theory is empirical, not special to a person, experimental two ways. One can compare the outcomes at two different points and compare two procedures. One can compare doses using the same procedure with different doses. It is UNETHICAL to compare to placebo in many cases! Whenever placebo comparison is unethical, one must compare alternate treatments!

In many applications like age enhancement, other than harsh calorie restriction, there is NO known method. Hence placebo trials are fair, provided that placebo-patients are given short readable facts about calorie-restriction and the trial is prepared with statistical estimate of departures.

Flaw seen

If two outcomes are seen at widely spaced points in time and disease history, while the acute phases of the disease may have been correctly addressed, the treatments may make the deeper causes worse and the next acute phase may in fact be worse!

This is greatly seen in the war in Afghanistan and Iraq experience in phase1. The overwhelming US strength was greatly used in acute phase, but the insurgents regrew and the problem became as bad in chronic phase!

Suppressing sugar release and reducing its concentration by insulin are two strategies in diabetes. The suppression by insulin is considered bad since I think that the useful role of insulin in youth becomes damaging in later years for diabetes 2 and Alzheimer’s – managing insulin-resistance by more insulin is stupid! Meanwhile, Metformin has beneficial effects by other pathways. This means that pure Metformin patients will see improved lifespan, pure insulin or near shorter lifespan, and largely metformin no gain.

First coMedicine trial

While any chronic disease like diabetes, heart trouble management etc shall be taken up, the founding trial only relates to age. Both Arya-method and test-age methods will be used for evaluating undertrials, the effects will be measured at start, death or when the clock strikes end-trial. The trial may continue.

The placebo-patients can undertake any life-extension methods except those being studied. The subject-patients will undergo one ECP,alternate day use Niagen and coQ10-pair, and take 1000 mg metformin if nondiabetic to 2000-2500 mg if diabetic. Ramp up to metformin may be needed. No food instructions are necessary as the amount  in normal food is negligible. I believe that improved feeling and 10 year extension in lifespan will be seen.

This marks the first statement of intentions and initial letter to Google (Kurzweil), NIH (National center for complementary and Integrative Health) etc. India Vaishali is perfect place to conduct the trial at very small cost but in ethical way under a tough US Citizen.